Sign in to view content

Intravitreal Bevacizumab vs. Bevacizumab with Dexamethasone for the Treatment of Exudative Age-Related Macular Degeneration

Reda Issa, MD

Video
Published 2019

Related

Wet AMD 5 Symposium
Annual Meeting Talks
2020
BiWeekly Anti-VEGF Dosing for Chronic Refractory Neovascular Age-Related Macular Degeneration Unresponsive to Standard Monthly Dosing
Eric W Schneider, MD
Updates from the Field
2019
Prevalence and Risk Factors for Early Hydroxychloroquine Retinopathy
Bobeck S Modjtahedi, MD
On Demand Cases, Courses, and Papers
2017

Category: AMD-Neovascular

See more